STUDY OF THE DYSLIPIDEMIA CONDITION AND ITS RISK FACTORS IN PSORIASIS PATIENTS AT CAN THO DERMATO-VENEROLOGY HOSPITAL IN 2020
Main Article Content
Abstract
Objective: To determine the prevalenceand risk factors of dyslipidemia in psoriasis patient. Subjects and method: This is a prospective cross-sectional descriptive study conducted on 90 psoriasis patients treated at Can Tho Dermatology Hospital in 2020. Results: The prevalence of dyslipidemia in the disease psoriasis was 60%, in which the disorder accounted for the highest proportion was hightriglycerid (33.3%), followed by low HDL by 30%, high cholesterol (20%) and finally high LDL-c (12.2%).However, we have not found any statistically significant risk factors of the disorder in psoriasis patients yet. Conclusion: The incidence of dyslipidemia in psoriasis patients was high, but the reasons behind that were still not clear.
Article Details
Keywords
Dyslipidemia, psoriasis
References
2. Lê Minh Phúc Nguyễn Tất Thắng (2012), "Nồng độ lipid máu trên bệnh nhân vảy nến tại bệnh viện Da Liễu Thành phố Hồ Chí Minh", Tạp chí Y học TP Hồ Chí Minh, 16(1), 260-268.
3. Lê Ngọc Diệp Trương Thị Mộng Thường (2012), "Chất lượng cuộc sống của bệnh nhân vảy nến đến điều trị tại bệnh viện Da Liễu TP.HCM từ 01/9/2010 đến 30/4/2011", Tạp chí Y học TP. Hồ Chí Minh, tập 16(phụ bản số 1), tr 284-292.
4. Trương Lê Anh Tuấn và Lê Ngọc Diệp (2012), "Mối liên quan giữa bệnh vảy nến và hội chứng chuyển hóa", 268-274.
5. Daudén E, Castañeda S & Suárez C et al (2013), "Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis", J Eur Acad Dermatol Venereol, 27, 1387-1404.
6. Evaluation Expert Panel on Detection, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002), "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report", Circulation, 106(3143-3421
7. Garshick MK & Kimball AB (2015), " Psoriasis and the life cycle of persistent life effects", Dermatol Clin; 3, 25-39.
8. Grozdev I, Korman N & Tsankov N (2014), "Psoriasis as a systemic disease", Clinics in Dermatology, 32, 343-350.